IOVANCE BIOTHERAPEUTICS, INC.
Developing personalized T-cell immunotherapies (TIL) to fight solid tumors and blood cancers.
IOVA | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 825 INDUSTRIAL ROAD, 94070 SAN CARLOS
- Website:
- https://www.iovance.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Iovance Biotherapeutics, Inc. is a commercial-stage biopharmaceutical company focused on innovating, developing, and delivering T-cell-based immunotherapies for cancer patients. The company's lead platform is Tumor-Infiltrating Lymphocyte (TIL) therapy, a personalized approach that harnesses a patient's own immune cells to recognize and attack cancer cells by targeting a variety of unique neoantigens on the tumor. This distinguishes it from therapies that act on shared antigens. Iovance is advancing TIL therapies through clinical trials for various solid tumors and is developing next-generation genetically modified TILs. The company also has a Peripheral Blood Lymphocyte (PBL) therapy platform for blood cancers. It operates a proprietary manufacturing facility, the Iovance Cell Therapy Center, in Philadelphia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all IOVANCE BIOTHERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IOVANCE BIOTHERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IOVANCE BIOTHERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
